Bill requires cradle-to-grave drug tracking; Generic drugmaker accused of forging docs;

> A pending California bill would impose strict new medication-tracking rules requiring that drugs be followed from the time they're created all the way through to the point at which they've dispensed in a pharmacy. FierceHealthIT

> FDA authorities are accusing Indian generic drug maker Ranbaxy Laboratories of forging documents, and are demanding that the drugmaker defend itself by turning over the documents for verification. FiercePharma

> The CDC is reporting that there have been about 8,000 reported adverse effects incidents due to vaccinations with cervical cancer vaccine Gardasil. FierceVaccines

> Recently, Medicare issued rules that would allow hospitals to bill for remote "telemedical" visits by consulting physicians. Here's some thoughts from readers, pro and con, on how those rules might work out. FierceHealthFinance

And Finally... With an economy like ours, a job search calls for creativity. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.